IMNN-001 (GEN-1)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for IMNN-001 (GEN-1), covering 2024-10-02 to 2024-10-02. Get the full timeline:
Most recent: Clinical Trial Update: Study of Safety & Biological Activity of IP IMNN-001 (also Known As GEN-1) with Neoadjuvant Chemo in Ovarian Cancer [Phase 1]